United Health Products, Inc.

United Health Products reported a net loss of $(315,842) for Q1 2026, a significant improvement from $(1,531,659) in Q1 2025, primarily due to reduced operating expenses. However, the company continues to face substantial doubt about its ability to continue as a going concern, citing recurring net losses, negative working capital, and insufficient revenue to cover operating expenses. Cash and cash equivalents declined sharply to $1,029 by March 31, 2026, from $65,249 at the end of 2025, further highlighting its precarious financial position.

United Health Products, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The company reported that the approximate market value of its common stock held by non-affiliates was $25,218,657 as of June 30, 2025. As of April 14, 2026, there were 258,690,253 shares of common stock issued and outstanding.